Brief: Royalty Pharma And Zealand Pharma Enter Into Rusfertide Funding Agreement For $100 Million
12/08/2026 22:23
BRIEF-Royalty Pharma And Zealand Pharma Enter Into Rusfertide Funding Agreement For $100 Million Aug 12 (Reuters) - Royalty Pharma PLC RPRX.O:
ROYALTY PHARMA AND ZEALAND PHARMA ENTER INTO RUSFERTIDE FUNDING AGREEMENT FOR $100 MILLION
Source text: ID:nGNX3nsvc7
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)